Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Avandia rosiglitazone endocrine data

The Journal of the American Medical Association published 2 meta-analyses of the diabetes drugs Avandia rosiglitazone from GSK and Actos pioglitazone from Takeda Pharmaceutical Co. Ltd. (Tokyo:4502, Osaka, Japan) and Eli Lilly and Co. (LLY,

Read the full 354 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers